European Myeloma Network B.v.

This study is testing an experimental drug called teclistamab for people with AL amyloidosis who have already tried other treatments. The drug works by helping the immune system target and destroy the abnormal plasma cells that produce harmful proteins. Researchers want to see if…

This study is testing whether a new treatment approach works better than current standard care for people newly diagnosed with multiple myeloma who cannot receive stem cell transplants. One group will receive standard medications, while the other will switch to an experimental dr…

This large Phase 3 study is testing whether adding a new drug called teclistamab to standard maintenance therapy (lenalidomide) works better than lenalidomide alone for people with newly diagnosed multiple myeloma who have had a stem cell transplant. The goal is to help keep the …

This study aims to collect and store blood and tissue samples from patients with multiple myeloma and related conditions. Researchers will gather samples and health information from 6,000 participants across multiple countries to create a large biobank for future research. The go…